<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H764916F84BDC4F82B8647BB5BC8B1067" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 5536 IH: Headache Education, Access, Diagnosis, and Care Health Equity Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-09-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5536</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250919">September 19, 2025</action-date><action-desc><sponsor name-id="T000482">Mrs. Trahan</sponsor> (for herself, <cosponsor name-id="B001315">Ms. Budzinski</cosponsor>, <cosponsor name-id="M001196">Mr. Moulton</cosponsor>, <cosponsor name-id="K000385">Ms. Kelly of Illinois</cosponsor>, and <cosponsor name-id="F000477">Mrs. Foushee</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To direct the Secretary of Health and Human Services to carry out a National Headache Disorders Initiative, to establish an Advisory Council on Headache Disorders Research, Care, and Services, and for other purposes.</official-title></form><legis-body id="HC8FB48BFDF214282B57E1E1EF3651457" style="OLC"><section id="HE86C0286867A4E26B1EECF8FE1616CCF" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Headache Education, Access, Diagnosis, and Care Health Equity Act</short-title></quote> or the <quote><short-title>HEADACHE Act</short-title></quote>.</text></section><section id="H992977AA5AB34ED7879D28B28CF7022C"><enum>2.</enum><header>Definition</header><text display-inline="no-display-inline">In this Act:</text><paragraph id="H6AFFEE4E8DA345EE9DA1550A4BFA644D"><enum>(1)</enum><header>Headache disorder</header><subparagraph id="H45630DAA0AD049C79F69836A9D56434F"><enum>(A)</enum><header>In general</header><text>The term <quote>headache disorder</quote> means a primary or secondary medical condition for which headache is a principal symptom.</text></subparagraph><subparagraph id="HA1C3FD28096C4F6ABBCEFE90E8DF2A35"><enum>(B)</enum><header>Inclusion of certain medical conditions</header><text>The medical conditions referred to in subparagraph (A) include migraine, cluster headache, tension-type headache, spinal cerebrospinal fluid (CSF) leak, idiopathic intracranial hypertension, new daily persistent headache, headache secondary to long COVID, orofacial pain disorders, post-traumatic headache secondary to traumatic brain injury, and headache disorders affecting vulnerable populations such as children, pregnant women, and older adults.</text></subparagraph></paragraph><paragraph id="H0C0B4690401B49B09E7BB1633F154B84"><enum>(2)</enum><header>Secretary</header><text>The term <quote>Secretary</quote> means the Secretary of Health and Human Services, except as otherwise specifically provided.</text></paragraph></section><section id="H7911795AF6FC4EF0ABFBB62BE39B997F"><enum>3.</enum><header>National Headache Disorders Initiative</header><subsection id="HE6D49615A8084993AD6F40F5A0CEA523"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall carry out an initiative, to be known as the National Headache Disorders Initiative (in this section referred to as the <quote>NHDI</quote>), in accordance with the requirements of this section.</text></subsection><subsection id="H9AD1E5FA9FB647EA98C8C996CF88B043"><enum>(b)</enum><header>Components</header><text>In carrying out the NHDI, the Secretary shall—</text><paragraph id="H75E942465354438EB97991707944EE5C"><enum>(1)</enum><text display-inline="yes-display-inline">establish and implement a comprehensive program to address the medical, societal, and economic impacts of headache disorders;</text></paragraph><paragraph id="H35939F90B7994D04A5513BE41960A833"><enum>(2)</enum><text>take such actions as may be necessary to increase the clinical and research workforce focused on the care of patients with headache disorders;</text></paragraph><paragraph id="H49A34CBECF434A4A855B25E2CA23C920"><enum>(3)</enum><text>coordinate with other Federal initiatives with missions that overlap with NHDI, including the Helping End Addiction Long-Term (HEAL) Initiative, the NIH Pain Consortium, the Interagency Pain Research Coordinating Committee, and the Centers of Excellence in Pain Education;</text></paragraph><paragraph id="HB88D94869E544B6398C02E9CEBAFA93F"><enum>(4)</enum><text>ensure that Federal resources available to support headache disorders research and services across all agencies are commensurate with the high disease burden exacted by these conditions;</text></paragraph><paragraph id="HA80DB1D157E149B880DECD9AB62B928A"><enum>(5)</enum><text display-inline="yes-display-inline">ensure prioritization of fundamental, translational, and clinical research to improve the speed, accuracy, and cost of diagnosis of headache disorders, and the development of innovative therapeutics to prevent and ameliorate the symptoms of headache disorders;</text></paragraph><paragraph id="HAD2BCED973274921823DF799A149A642"><enum>(6)</enum><text>improve protocols for the diagnosis and the coordination of care of headache disorders, including care pathways that address comorbid medical conditions;</text></paragraph><paragraph id="HD8F33C7E786549559A4A134E84C0B8AF"><enum>(7)</enum><text>enhance the epidemiological database of headache disorders to ensure comprehensive and inclusive data collection that improves clinical care, research, and public health efforts while addressing disparities in diagnosis, treatment, and access to care;</text></paragraph><paragraph id="HBF5CAB4B39BA4CA89C12A80FB3EA9081"><enum>(8)</enum><text>enhance social research of headache disorders and coordinate public awareness campaigns to reduce stigma associated with such disorders; and</text></paragraph><paragraph id="HB4033FD398FD4A21BC264E3E2346A66C"><enum>(9)</enum><text>coordinate with international bodies to integrate and inform global efforts surrounding headache disorders.</text></paragraph></subsection><subsection id="H38F3E3D753AB457C93B83B113E9E86EA"><enum>(c)</enum><header>Duties</header><text>The Secretary shall—</text><paragraph id="HDDE6BBC873D247B3BFADC512F3D3B6C6"><enum>(1)</enum><text display-inline="yes-display-inline">oversee the establishment and updating of the NHDI; and</text></paragraph><paragraph id="H3A21D8E825A94064AFFCC1EF20C539D2"><enum>(2)</enum><text>evaluate all Federal programs related to headache disorders, including budget requests and approvals.</text></paragraph></subsection></section><section id="H0E2A503C2A92425898066555DD728B22"><enum>4.</enum><header>Advisory Council on Headache Disorders Research, Care, and Services</header><subsection id="H3549FEFA404D402E9213C9DF99FBC1B9"><enum>(a)</enum><header>Establishment</header><text display-inline="yes-display-inline">The Secretary shall establish and maintain an Advisory Council on Headache Disorders Research, Care, and Services (referred to in this section as the <quote>Advisory Council</quote>) for the purpose of advising the Secretary on matters relating to headache disorders.</text></subsection><subsection id="H637970C9DA664DA887F245232A49EE0F"><enum>(b)</enum><header>Membership</header><paragraph id="H78558AD0B91D4DBEA92E7680AF362EEF"><enum>(1)</enum><header>Federal members</header><text display-inline="yes-display-inline">The Advisory Council shall be comprised of experts, to be appointed by the Secretary, who collectively are from various backgrounds and perspectives, including at least one member from each of the following:</text><subparagraph id="HFC4B88FE0B6945D2BDBF92C58E2DDA44"><enum>(A)</enum><text display-inline="yes-display-inline">The National Institutes of Health.</text></subparagraph><subparagraph id="HA035605A18F44EED9BA978330C8C6918"><enum>(B)</enum><text>The Office of Research on Women’s Health.</text></subparagraph><subparagraph id="H01F5BCE3BC40465FB60DEB6E4EE8B288"><enum>(C)</enum><text>The Food and Drug Administration.</text></subparagraph><subparagraph id="H816F2E5025084C0FAACA5A163522FB4E"><enum>(D)</enum><text>The Centers for Medicare &amp; Medicaid Services.</text></subparagraph><subparagraph id="H5D2EEE12934F4F78BB091EDA673B3BFD"><enum>(E)</enum><text>The Indian Health Service.</text></subparagraph><subparagraph id="H3933FA7120754C35AB184D736C72F4C6"><enum>(F)</enum><text>The Department of Veterans Affairs.</text></subparagraph><subparagraph id="HBAB4136260F04E8AB63AC8B23255EB46"><enum>(G)</enum><text>The Department of Defense.</text></subparagraph><subparagraph id="H23518512100F43C9817A0EC1C056E64E"><enum>(H)</enum><text>The Centers for Disease Control and Prevention.</text></subparagraph><subparagraph id="H268E7E65A7324712AF96C4A36BA31371"><enum>(I)</enum><text>The Agency for Healthcare Research and Quality.</text></subparagraph><subparagraph id="H1EDD89A8A2074646B52E609CBC3F8C6B"><enum>(J)</enum><text>The Patient-Centered Outcomes Research Institute.</text></subparagraph><subparagraph id="HAC28952F45FB45228BFB0C17D8D47411"><enum>(K)</enum><text>The Advanced Research Projects Agency for Health.</text></subparagraph><subparagraph id="H7C42C9DDD8384D0AB63E4390CE6C81C5"><enum>(L)</enum><text>The National Center for Complementary and Integrative Health.</text></subparagraph><subparagraph id="HEA8DEB36183C404595CFDFE042407DC8"><enum>(M)</enum><text>The Department of Education.</text></subparagraph><subparagraph id="HF3000810BFB2493F88470DB56DBED895"><enum>(N)</enum><text>Other Federal departments and agencies.</text></subparagraph></paragraph><paragraph id="HDB9BF97CC44D4A688CA5396439C13B91"><enum>(2)</enum><header>Non-Federal members</header><text display-inline="yes-display-inline">In addition to the members specified in paragraph (1), the Advisory Council shall include 12 members, to be appointed by the Secretary, who shall include representatives of minority communities, communities disproportionately affected by headache disorders, and communities underrepresented in headache disorders research, who shall each be from outside the Federal Government, and who shall include the following:</text><subparagraph id="H109E1A5213864514818C1581C8418230"><enum>(A)</enum><text display-inline="yes-display-inline">Two individuals who are patient advocates, including one individual who is living with migraine and one individual with a non-migraine headache disorder.</text></subparagraph><subparagraph id="HBF7F51FF6E204E4CB111DEF56B393AE1"><enum>(B)</enum><text>An individual who is a caregiver of a child or adolescent with a headache disorder.</text></subparagraph><subparagraph id="HCC6DB61E6B084817BBC7F705F5E918F9"><enum>(C)</enum><text display-inline="yes-display-inline">Individuals who are healthcare providers specializing in headache (those with a patient base where greater than 80 percent are headache patients), including—</text><clause id="H860A90B65A914AD99307E6E39B247073"><enum>(i)</enum><text>at least one individual who is Doctor of Medicine or Doctor of Osteopathic Medicine;</text></clause><clause id="H48EBC35231BA408DB6FB4DC66D1E6922"><enum>(ii)</enum><text>at least one individual who is an Advanced Practice Provider;</text></clause><clause id="H214A6C12300C440783858D6E16DD9E8C"><enum>(iii)</enum><text>at least one individual who is a behavioral health specialist;</text></clause><clause id="H3220FF293D0341A79B2E921B7FD623B1"><enum>(iv)</enum><text>at least one individual who is an orofacial pain specialist;</text></clause><clause id="H3928DDA9D6C247DFA62184E0F398A578"><enum>(v)</enum><text>at least one individual who is a front-line provider (such as a primary care physician or emergency care provider); and</text></clause><clause id="H1957DF37930B4403B85F2CF2565CD3CC"><enum>(vi)</enum><text>at least one individual who is a researcher with expertise in headache disorders.</text></clause></subparagraph><subparagraph id="H7425E2D810964447B78DA00C964E24EE"><enum>(D)</enum><text display-inline="yes-display-inline">At least one individual who is a representative of a non-profit patient advocacy organization focused exclusively on headache disorders.</text></subparagraph></paragraph></subsection><subsection id="H1888C387FFEF43909B5DAEAF2D39298C"><enum>(c)</enum><header>Meetings</header><paragraph id="H99AED53725E04CF08AAAF7B992D1C599"><enum>(1)</enum><header>Frequency</header><text display-inline="yes-display-inline">The Advisory Council shall meet—</text><subparagraph id="HA32810A8E26F40EE8C612D0BC0498281"><enum>(A)</enum><text>at least once each quarter during the 2-year period beginning on the date on which the Advisory Council is established; and</text></subparagraph><subparagraph id="HB403D8B133DC445F853A6F0174904F51"><enum>(B)</enum><text>at the Secretary’s discretion after the expiration of such period.</text></subparagraph></paragraph><paragraph id="HDFDAE6DCE0EE453098127F2373A2A5B7"><enum>(2)</enum><header>Annual research meeting</header><text display-inline="yes-display-inline">Not later than two years after the date of enactment of this Act, and every year thereafter, the Advisory Council shall convene a meeting of Federal and non-Federal organizations to discuss headache disorders research.</text></paragraph></subsection><subsection id="H73B2571A0650465DA4DBC814D19B8B9A"><enum>(d)</enum><header>Termination</header><text display-inline="yes-display-inline">The Advisory Council shall terminate on the sunset date specified in section 7.</text></subsection></section><section id="HDDC2FBB19FD44ADA9E7645E104E1468A"><enum>5.</enum><header>Data sharing</header><subsection id="H16D5A7D0E27943AB9F6C6D5FC7BBF772"><enum>(a)</enum><header>In general</header><text>The heads of Federal agencies, within and outside the Department of Health and Human Services, that have data relating to headache disorders shall, at the request of the Secretary, share such data with the Secretary to enable the Secretary to complete the report required under section 6.</text></subsection><subsection id="H14313E8EC64C4C9D8D35FB805BDAC1C4"><enum>(b)</enum><header>Included data</header><text>The data-sharing requirement under subsection (a) includes standardized data collection across agencies and integration with non-Federal sources, such as electronic health records, patient registries, and population health surveys.</text></subsection></section><section id="H1739C8717CD5431EB207BC688D71CCFF"><enum>6.</enum><header>Annual report to Congress</header><subsection id="HED7DCDD38C34494ABA5CBEBC17939365"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall submit to Congress an annual report containing information relating to headache disorders, as specified in subsection (b).</text></subsection><subsection id="HB6AF5DFA2A6544E09A590CED4D59BB50"><enum>(b)</enum><header>Contents</header><text>The annual report shall include the following:</text><paragraph id="H6DBEA69BE80D41C29660CF2C6D47FCD6"><enum>(1)</enum><text>An evaluation of all federally funded efforts relating to headache disorders research, clinical care, and other treatment programs and their outcomes.</text></paragraph><paragraph id="HF9467AF7DFE34ECEBA24A75872AF005A"><enum>(2)</enum><text>An evaluation of program performance, mission, and purpose, including data on headache disparities across racial, ethnic, socioeconomic, and geographic lines.</text></paragraph><paragraph id="HAB9004E2DB2246A1A157C4E423EB8EBF"><enum>(3)</enum><text>Recommendations for priority actions, including—</text><subparagraph id="H73AA0E2ADECE4ADCAEC4B0A12AA08B71"><enum>(A)</enum><text>reducing the financial impact of headache disorders on Medicare and other federally funded programs;</text></subparagraph><subparagraph id="H86DE96D52F0F476C8023695B8C04D47B"><enum>(B)</enum><text>improving health outcomes by updating diagnostic protocols, improving access to care, and advancing therapeutic research; and</text></subparagraph><subparagraph id="H0CCDF76FDF154F30A9C2EDAB6B71A440"><enum>(C)</enum><text>strategies to increase public awareness and reduce stigma.</text></subparagraph></paragraph><paragraph id="H217C1F72BF6047DE9A7D01A587D4CBE2"><enum>(4)</enum><text>An annually updated national plan that addresses both short-term and long-term objectives for addressing headache disorders.</text></paragraph></subsection></section><section id="H0BE9EA01FAEB4FBC8563650739793990"><enum>7.</enum><header>Sunset date</header><text display-inline="no-display-inline">This Act shall cease to be effective on the date that is 5 years after the date of enactment of this Act.</text></section></legis-body></bill> 

